Immutep (IMMP) Other Non Operating Income (2015 - 2024)

Immutep (IMMP) posted Other Non Operating Income of $74771.6 for Q2 2024, down 78.38% on a QoQ basis from $345848.4 in Q2 2019.

Immutep (IMMP) Other Non Operating Income (2015 - 2024) Analysis & Trends

Immutep's Other Non Operating Income history runs 5 years deep, the most recent figure standing at $74771.6 for Q2 2024.

Quarterly Other Non Operating Income changed N/A year-over-year to $74771.6 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $700582.9 (changed N/A YoY) and the FY2024 annual result came in at $74771.6, changed N/A from the prior year.
Other Non Operating Income was $74771.6 for Q2 2024 at Immutep, down from $345848.4 in the prior quarter.
Across five years, Other Non Operating Income topped out at $74771.6 in Q2 2024 and bottomed at $74771.6 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Immutep	569.08 Mn	569.08 Mn	-

Download Data